We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

71 hedge funds and large institutions have $227M invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 39 increasing their positions, 12 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 12

66% more capital invested

Capital invested by funds: $137M → $227M (+$90.4M)

9% less funds holding

Funds holding: 78 → 71 (-7)

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
71
Holders Change
-7
Holders Change %
-8.97%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
11
Increased
39
Reduced
12
Closed
17
Calls
$138K
Puts
–
Net Calls
+$138K
Net Calls Change
+$138K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.1M
2
BFA
BlackRock Fund Advisors
California
+$3.59M
3
OAM
Oxford Asset Management
United Kingdom
+$1.85M
4
CCM
Century Capital Management
Massachusetts
+$1.69M
5
PC
Polar Capital
United Kingdom
+$1.62M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$11.4M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$3.59M
3
MC
Mitra Capital
Massachusetts
-$2.97M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.49M
5
BC
Boxer Capital
California
-$2.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
FSA
26
Franklin Street Advisors
North Carolina
$1.09M +$146K +17,100 +20%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$947K +$333K +38,915 +80%
Charles Schwab
28
Charles Schwab
California
$872K +$407K +47,602 +143%
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$734K -$340K -39,735 -37%
CAM
30
ClariVest Asset Management
California
$734K +$582K +68,036 New
BCM
31
Bridgeway Capital Management
Texas
$651K +$430K +50,250 +498%
Goldman Sachs
32
Goldman Sachs
New York
$636K +$81.3K +9,506 +19%
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$595K +$228K +26,633 +93%
Point72 Asset Management
34
Point72 Asset Management
Connecticut
$594K -$3.59M -419,926 -88%
MC
35
Mitra Capital
Massachusetts
$594K -$2.97M -347,822 -86%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$541K – – –
Deutsche Bank
37
Deutsche Bank
Germany
$510K +$362K +42,303 +820%
NFA
38
Nationwide Fund Advisors
Ohio
$502K +$68.5K +8,004 +21%
TA
39
Teachers Advisors
New York
$450K +$357K +41,690 New
AA
40
ALPS Advisors
Colorado
$437K +$136K +15,920 +65%
DC
41
Deere & Company
Illinois
$411K +$326K +38,100 New
SIM
42
Spark Investment Management
New York
$310K +$88.9K +10,400 +57%
CS
43
Credit Suisse
Switzerland
$278K +$8.97K +1,049 +4%
HLA
44
Hamilton Lane Advisors
Pennsylvania
$277K – – –
ProShare Advisors
45
ProShare Advisors
Maryland
$266K +$59.8K +6,991 +40%
VEA
46
Virtus ETF Advisers
New York
$264K +$59.3K +6,933 +40%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$250K +$88.8K +10,378 +81%
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$228K +$181K +21,143 New
SO
49
STRS Ohio
Ohio
$204K – – –
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$203K +$81.5K +9,534 +103%
1
2
3 4

VTAE Hedge Fund Activity: Q2 2016 in Review

71 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q2 2016, worth a combined $227M — up 66% from $137M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of VTAE and 11 opened new positions — a net loss of 6 holders — while 12 trimmed existing stakes and 39 added.

The largest buyer was Fidelity Investments, adding an estimated $14.1M. The largest seller was BVF Inc, cutting an estimated $11.4M.

  • 71 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q2 2016, down from 78 in Q1 2016.
  • Funds reported $227M of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q2 2016, up 66% quarter-over-quarter.
  • 11 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q2 2016 and 17 closed out, a net change of -6 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK buyer in Q2 2016 was Fidelity Investments, an estimated $14.1M added.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q2 2016 was BVF Inc, an estimated $11.4M sold.

Based on aggregated 13F filings for Q2 2016.